,0,1
0,hsa-miR-186-5p,Promotes apoptosis [473] and suppresses CRC [474]
1,[CAAAGAAUUCUCCUUUUGGGCU],Promotes apoptosis [473] and suppresses CRC [474]
2,,"Suppresses CRC [475,476],glioblastoma [477],GC [478],salivary adenoid cystic"
3,,carcinoma [479] and CML [480]; targets genes in lithium response in bipolar disorder [481];
4,hsa-miR-320a,regulates fibrotic process in interstitial lung disease of systemic sclerosis [482]; regulates cell
5,ICUCCCCUCCGCCUUCUCUUCCCG,proliferation and apoptosis in multiple myeloma [483];regulates erythroid differentiation [484]
6,GUUCUUCCCGGAGUCGGGAAAAGCUG],controls glucagon expression [485]; regulates cell proliferation and apoptosis in multiple
7,,myeloma [483]; stimulates endometrial stromal cell migration during preimplantation embryo
8,,stage [486]; improves skeletal muscle mitochondrial metabolism [487]
9,,Involved in Ang II-induced phenotypic transformation of smooth muscle cells in
10,,hypertension [488]; suppresses starvation-induced cardiomyocyte autophagy [488]; improves
11,hsa-miR-181b-5p,anti-tumor cytotoxic T cell response in B cells of CLL [489]; inhibits trophoblast cell migration
12,[AACAUUCAUUGCUGUCGGUGGGU],and invasion in multiple abnormal trophoblast invasion [490]; modulates cell migratory
13,,proteins in endometrial stromal cells [491]; suppresses the progression of epilepsy [492];
14,, suppresses gallbladder carcinoma [493]
15,,"Regulates angiogenesis, apoptosis, cell differentiation, oxidative stress and hypoxia [494];"
16,hsa-miR-30e-5p,NSCLC [496] and squamous cell carcinoma of the head and neck [497]; enhances innate
17,[UGUAAACAUCCUUGACUGGAAG],
18,,considered as a potential target for curbing metastatic spread in P53-deficient tumors [499].
19,hsa-miR-103a-3p,Regulates BDNF expression in follicular fluid [465]; suppresses PC [500]; aggravates renal cell
20,[AGCAGCAUUGUACAGGGCUAUGA],carcinoma [501]; regulates Wnt signaling pathway in colorectal carcinoma [502].
21,,"Mediates downregulation of BRCA1,impacting DNA repair and sensitivity to PARP"
22,hsa-miR-182-5p,"inhibitors [503]; suppresses CRC [504], renal cell carcinoma [505], bladder cancer [506] and"
23,[UUUGGCAAUGGUAGAACUCACACU],prostate cancer [507]; acts as glial cell line-derived neurotrophic factor GDNF mimics
24,,dopaminergic midbrain neurons [508];associates with renal cancer cell mitotic arrest [509]
25,hsa-miR-151a-3p,"Enhances slug-dependent angiogenesis and regulates multiple functions in the lung, such as"
26,[CUAGACUGAAGCUCCUUGAGG],"cell growth, motility, partial EMT and angiogenesis [510]."
27,hsa-miR-335-5p,"Regulates bone homeostasis [511]; suppresses GC [512], uterine leiomyoma [513] and"
28,[UCAAGAGCAAUAACGAAAAAUGU],ESCC [514]; regulates cardiac mesoderm and progenitor cell differentiation [515]
29,hsa-miR-25-3p,Suppresses hepatocytes [516] and regulates osteoblast differentiation of human aortic valve
30,[CAUUGCACUUGUCUCGGUCUGA],interstitial cells [517].
31,hsa-let-7g-5p,Suppresses epithelial ovarian cancer [517] and glioblastoma [518]; and alleviates murine
32,[UGAGGUAGUAGUUUGUACAGUU],collagen-induced arthritis by inhibiting Th17 cell differentiation [519].
33,hsa-miR-200c-3p,"Suppresses prostate carcinoma [520], renal cell carcinoma [521] and epithelial ovarian"
34,[UAAUACUGCCGGGUAAUGAUGGA],capacity of macrophages [524]
35,,Suppresses GC [525] and prostate cancer [526]; protects cells from
36,hsa-miR-30c-5p,hypoxia-reoxygenation-induced apoptosis and induces cell proliferation and anti-apoptotic
37,[UGUAAACAUCCUACACUCUCAGC],and proliferative effects [527]; reduces cellular migration and pro-angiogenic gene expression
38,,in extracellular vesicle EV-recipient cells [528]
39,,"regulates hypoxia [529]; suppresses breast cancer [530], osteosarcoma [531], THCA, soft tissue"
40,hsa-miR-429,"sarcoma [532],cervical cancer [533],GC [534],diffuse large B-cell lymphoma [535],esophageal"
41,[UAAUACUGUCUGGUAAAACCGU],"carcinoma [536],HCC[537,538],glioblastoma [539],NPC [540],PC cancer [541],THCA [542]"
42,,OSCC [543] and renal cell carcinoma [544]; inhibits bone metastasis in breast cancer [545];
43,,regulates the transition between HIF1A and HIF3A expression in human endothelial cells [546]
44,hsa-miR-99b-5p,
45,[CACCCGUAGAACCGACCUUGCG],"Suppresses primary myotubes [547], epidermal keratinocytes and cervical cancer cells [548]."
46,,Modulates CYP2C19 in human liver cells [549]; suppresses cell proliferation [550]; activates
47,,"hepatic stellate cells, which moderate their profibrogenic phenotype, supporting the use of"
48,,miR-29a agonists for treating liver fibrosis [551]; regulates tumorigenicity and TME
49,,"development [552]; involved in the progression of HCC,which elucidates its potential"
50,,theragnostic implications [552]; suppresses GC [553] and renal cell carcinoma by regulating
51,,E2F1 expression by long non-coding RNA H19 [554]; induces TNF in endothelial
52,hsa-miR-29a-3p,dysfunction [555]; mediates tumor immune infiltration in breast invasive carcinoma [556]; acts
53,[UAGCACCAUCUGAAAUCGGUUA],as a protective factor for fibrogenesis in gluteal muscle contracture557l;regulates osteoblast
54,,in ulcerative colitis [559];regulates and restores endothelial function in normal people and
55,,"cardiometabolic disorders, respectively [560]; regulates peripheral glucocorticoid receptor"
56,,"signaling [561];suppresses CRC[562],gliomas[563],head and neck squamous cell"
57,,"carcinoma [564], prostate cancer [565],GC [553],PTC [566], lung cancer [567], cervical cancer"
58,,[568] and endometrial cancer [569]; enhances the radiosensitivity of OSCC cells [570];
